website banner

Programme​​

Conference Programme

This document provides descriptions of the 15 parallel workshops. As a living document, it will be regularly updated with the latest details on workshop speakers.

Conference Keynotes

dr. Daniëlle Jansen, former Dutch Member of Parliament & Minister of Health, Welfare and Sport

Daniëlle Jansen (1970) was Minister of Health, Welfare and Sport in the Netherlands on behalf of the political party ‘New Social Contract’ in the caretaker cabinet of Dutch Prime Minister Schoof from 19 June 2025 to 23 August 2025. Before that, she was a member of the House of Representatives from December 2023 to June 2025. She was affiliated with the University of Groningen as an Associate Professor of Health Systems and the Organization of Care for Children and Young Adults. She started there as a researcher in 2011. As a Member of Parliament, Ms. Jansen focused on prevention, curative care, and healthcare affordability. In addition, she was a member of the temporary committee on Fundamental Rights and Constitutional Review.

dr. Ellen ‘t Hoen, Director, Medicines Law & Policy

Ellen ‘t Hoen, LLM PhD, is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies. From 1999 until 2009 she was the director of policy for Médecins sans Frontières’ Campaign for Access to Essential Medicines. In 2009 she joined UNITAID in Geneva to set up the Medicines Patent Pool (MPP). She was the MPP’s first executive director until 2012. Between 2005 and 2021 she was listed five times as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property. She has worked as an advisor to a number of governments, NGOs and international organisations. She is currently a researcher at the University Medical Centre at the University of Groningen, The Netherlands. In 2020, she was appointed Officer of the Order of Oranje-Nassau, a royal award given by the King of the Netherlands for her international work on equitable access to affordable medicines. She has published widely on medicines law and policy issues. Her book “Private Patents and Public Health: Changing intellectual property rules for public health” published July 2016 was awarded the 2017 Prix Prescrire for a “major reference work on access to medicines” by French healthcare journal La Revue Prescrire. She has a Masters of Laws from the University of Amsterdam and a PhD from the University of Groningen.

Mr. Martin Harvey Allchurch, Head of International Affairs, European Medicines Agency

Martin Harvey is Head of International Affairs at the European Medicines Agency since October 2021. He joined the EMA legal team in 1995 after several years as a European affairs consultant in Brussels. He has headed the Office of the Executive Director, served as Head of Communication, before later moving to the Agency's International Affairs team. He took an 18-month career break with UNITAID, the WHO-hosted partnership dedicated to innovation in global health from 2019-2020. Martin holds law degrees from the University of Dundee (UK) and the Vrije Universiteit Brussels (Belgium).

Dr. Andy Gray, Senior Lecturer, University of Kwa-Zulu Natal & Co-Chair, Lancet Commission

Andy Gray BPharm, MSc (Pharm), PhD, FPS, FFIP is a pharmacist whose research interests include policy analysis (in particular, the development and implementation of National Medicines Policies), rational medicines use and the application of antiretroviral therapy in resource-constrained settings. He is a Senior Lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. He is co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. He was appointed to the South African National Essential Medicines List Committee in 2013. He is currently chair of the Names and Scheduling Committee of the South African Health Products Regulatory Authority (SAHPRA) and serves on its Legal Committee and Pharmacovigilance Committee. He is a Member of the World Health Organization’s Expert Panel on Drug Policies and Management and has served as a member, rapporteur and co-chairperson of the Expert Committee on the Selection and Use of Essential Medicines, as chairperson of the sub-committee on Essential Medicines for Children, and on the WHO Guidelines Review Committee. He has served as a Co-Chair of the Lancet Commission on Essential Medicines for Universal Health Coverage (2017) and is a Co-Chair of the Lancet Commission on Accelerating Progress on Essential Medicines (2025-2027).